As of 2024-12-12, the Fair Value of Bristol-Myers Squibb Co (BMY) is -17.89 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 56.65 USD, the upside of Bristol-Myers Squibb Co is -131.58%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | 3,439.00 | -9,015.00 | 6,994.00 | 6,327.00 | 8,025.00 | 3,154.00 |
| YoY growth | -30.10% | -362.14% | 177.58% | -9.54% | 26.84% | -39.47% |
| Market Cap (mil) | 114,896.40 |
| P/E | |
| Forward P/E | 15.39x |
| EPS | -3.58 |
| Avg earnings growth rate | -39.47% |
| TTM earnings | -7,258.00 |